Iterum Therapeutics plc
ITRM · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$8,979 | -$6,509 | -$4,891 | -$6,582 |
| Dep. & Amort. | $355 | $351 | $349 | $261 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $56 | $61 | $89 |
| Change in WC | -$1,040 | -$171 | -$266 | -$1,420 |
| Other Non-Cash | $1,816 | $1,522 | $1,687 | $3,396 |
| Operating Cash Flow | -$7,848 | -$4,751 | -$3,060 | -$4,256 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$13 | $0 | -$2 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $1,100 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$13 | $0 | -$2 | $1,100 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$109 | $0 | $0 | $0 |
| Stock Issued | $5,767 | $5,120 | $6,357 | $13,877 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | -$14,745 | $0 |
| Financing Cash Flow | $5,658 | $5,120 | -$8,388 | $13,877 |
| Forex Effect | $179 | $5 | -$23 | -$2 |
| Net Chg. in Cash | -$2,024 | $374 | -$11,473 | $10,719 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $13,026 | $12,686 | $24,159 | $13,440 |
| End Cash | $11,002 | $13,060 | $12,686 | $24,159 |
| Free Cash Flow | -$7,860 | -$4,751 | -$3,062 | -$4,256 |